UNSPSC 51263300: Adrenergic blocking agents, synthesized

This classification denotes Adrenergic blocking agents composed of multiple constituents, with no dominant constituent.

UNSPSC 51263300 Adrenergic blocking agents, synthesized (Class) covers pharmaceutical products state and local health agencies procure to support community health and emergency response initiatives. The recent activity shows state and local governments buying naloxone (an opioid antagonist and adrenergic blocking agent) and related drug deactivation systems through competitive bidding processes. Issuing bodies include county health departments and community health programs pursuing emergency preparedness and substance-abuse mitigation, with procurement managed through standard IFB processes and electronic submission portals.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, requesting 1,900 units of naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The IFB deadline was July 26, 2023, and the contract includes a two-year initial term with an optional one-year renewal. Vendors must provide unit pricing, meet E-Verify and drug-free workplace requirements, carry workers' compensation and commercial general liability insurance, and absorb all shipping and delivery costs in their bids. The procurement is potentially FEMA-funded, introducing compliance requirements under the Clean Air Act and Federal Water Pollution Control Act. The source shows limited recent activity under this code; the single identified opportunity from Seminole County represents the available benchmark for understanding current state and local demand.